|
|
|
Volumn 145, Issue 2, 1997, Pages 123-125
|
|
Second European Stroke Prevention Study (ESPS 2): clinical and pharmacological implications.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
PROSTAGLANDIN SYNTHASE INHIBITOR;
CEREBROVASCULAR DISEASE;
EDITORIAL;
EUROPE;
HUMAN;
ASPIRIN;
CEREBROVASCULAR DISORDERS;
CYCLOOXYGENASE INHIBITORS;
EUROPE;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
|
|
EID: 0031565178
PISSN: 0022510X
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (18)
|
|
References (0)
|
